Rigel Pharma (RIGL) Misses Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $35.61 -0.34%
Financial Fact:
Total costs and expenses: 26.5M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Financial Fact:
Total costs and expenses: 26.5M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Rigel Pharma (NASDAQ: RIGL) reported Q1 EPS of ($0.16), $0.02 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $16.74 million versus the consensus estimate of $17.54 million.
For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance
- Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
